- Home
- PLRX vs FFWM Comparison
PLRX vs FFWM Comparison
Compare PLRX & FFWM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PLRX | FFWM |
|---|---|---|
| Founded | 2015 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 93.3M | 475.8M |
| IPO Year | 2020 | 2014 |
Fundamental Metrics
Financial Performance| Metric | PLRX | FFWM |
|---|---|---|
| Price | $1.24 | $6.07 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 11 | 3 |
| Target Price | $3.79 | ★ $6.17 |
| AVG Volume (30 Days) | ★ 1.9M | 751.9K |
| Earning Date | 11-06-2025 | 01-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $159,621,000.00 |
| Revenue This Year | N/A | $166.48 |
| Revenue Next Year | N/A | $6.86 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 47.55 |
| 52 Week Low | $1.10 | $4.42 |
| 52 Week High | $15.00 | $7.68 |
Technical Indicators
Market Signals| Indicator | PLRX | FFWM |
|---|---|---|
| Relative Strength Index (RSI) | 34.01 | 70.74 |
| Support Level | $1.17 | $5.66 |
| Resistance Level | $1.35 | $6.11 |
| Average True Range (ATR) | 0.12 | 0.17 |
| MACD | -0.03 | 0.09 |
| Stochastic Oscillator | 15.38 | 97.81 |
Price Performance
Historical ComparisonAbout PLRX Pliant Therapeutics Inc.
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.
About FFWM First Foundation Inc.
First Foundation Inc is a financial services company. It is engaged in providing investment management and financial planning services for high-net-worth individuals, retirement plans, charitable institutions, and private foundations. The company focuses on segments namely Banking and Wealth Management. It also offers loans to individuals and entities that own and operate multifamily residential and commercial real estate properties as well as business banking products and services to small to moderate-sized businesses, professional firms, and consumer banking products and services to individuals.